Protagonist Therapeutics, Inc Contracts & Agreements

68 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Protagonist Therapeutics, Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Protagonist Therapeutics, Inc
Biotechnology
2025
Amendment No. 1 to Amended and Restated License and Collaboration Agreement between Janssen Biotech, Inc. and Protagonist Therapeutics, Inc.
License Agreements
Protagonist Therapeutics, Inc
Biotechnology
2025
Third Amendment to Radnor Technology and Research Center Office and Cafeteria Lease between BMR-Pacific Research Center LP and Protagonist Therapeutics, Inc.
Lease Agreements
Protagonist Therapeutics, Inc
Biotechnology
2024
License and Collaboration Agreement between Protagonist Therapeutics, Inc. and Takeda Pharmaceuticals USA, Inc. (January 31, 2024)
License Agreements
Protagonist Therapeutics, Inc
Biotechnology
DE
2024
Description of Protagonist Therapeutics, Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Protagonist Therapeutics, Inc
Biotechnology
2024
Protagonist Therapeutics, Inc. Pre-Funded Warrant to Purchase Common Stock
Warrant Agreements
Protagonist Therapeutics, Inc
Biotechnology
NY
2023
Underwriting Agreement between Protagonist Therapeutics, Inc. and J.P. Morgan Securities LLC, Jefferies LLC, and Piper Sandler & Co. (April 2023)
Underwriting Agreements
Protagonist Therapeutics, Inc
Biotechnology
NY
2023
Description of Protagonist Therapeutics, Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Protagonist Therapeutics, Inc
Biotechnology
2023
Protagonist Therapeutics Inc. Employment Offer Letter to Arturo Molina as Chief Medical Officer
Employment Agreements
Protagonist Therapeutics, Inc
Biotechnology
2023
Employee Severance Agreement between Protagonist Therapeutics, Inc. and Arturo Molina, M.D.
Severance Agreements
Protagonist Therapeutics, Inc
Biotechnology
CA
2023
Description of Protagonist Therapeutics, Inc. Securities Registered Under Section 12 of the Exchange Act
Stock Agreements
Protagonist Therapeutics, Inc
Biotechnology
2022
Amended and Restated License and Collaboration Agreement between Janssen Biotech, Inc. and Protagonist Therapeutics, Inc.
License Agreements
Protagonist Therapeutics, Inc
Biotechnology
NY
2021
Arbitration Resolution Agreement between Zealand Pharma A/S and Protagonist Therapeutics, Inc. (August 4, 2021)
Settlement Agreements
Protagonist Therapeutics, Inc
Biotechnology
2021
Second Amendment to Lease Agreement between BMR-Pacific Research Center LP and Protagonist Therapeutics, Inc.
Lease Agreements
Protagonist Therapeutics, Inc
Biotechnology
2021
Underwriting Agreement between Protagonist Therapeutics, Inc. and J.P. Morgan Securities LLC, Jefferies LLC, and Piper Sandler & Co. (June 15, 2021)
Underwriting Agreements
Protagonist Therapeutics, Inc
Biotechnology
NY
2021
Description of Protagonist Therapeutics, Inc. Securities Registered Under Section 12 of the Exchange Act
Stock Agreements
Protagonist Therapeutics, Inc
Biotechnology
2021
Underwriting Agreement between Protagonist Therapeutics, Inc. and J.P. Morgan Securities LLC, SVB Leerink LLC, and Piper Sandler & Co. (December 2020)
Underwriting Agreements
Protagonist Therapeutics, Inc
Biotechnology
NY
2020
Employee Severance Agreement between Protagonist Therapeutics, Inc. and Donald Kalkofen
Severance Agreements
Protagonist Therapeutics, Inc
Biotechnology
CA
2020
Underwriting Agreement between Protagonist Therapeutics, Inc. and Jefferies LLC, BMO Capital Markets Corp. (May 2020)
Underwriting Agreements
Protagonist Therapeutics, Inc
Biotechnology
NY
2020
Description of Protagonist Therapeutics, Inc. Securities Registered Under Section 12 of the Exchange Act
Stock Agreements
Protagonist Therapeutics, Inc
Biotechnology
2020
Protagonist Therapeutics, Inc. Amended and Restated 2018 Inducement Plan
Bonus & Incentive Agreements
Protagonist Therapeutics, Inc
Biotechnology
DE
2020
Open Market Sale Agreement between Protagonist Therapeutics, Inc. and Jefferies LLC (November 27, 2019)
Equity Distribution Agreements
Protagonist Therapeutics, Inc
Biotechnology
NY
2019
Employee Severance Agreement between Protagonist Therapeutics, Inc. and Samuel Saks, M.D.
Severance Agreements
Protagonist Therapeutics, Inc
Biotechnology
CA
2019
First Amendment to License and Collaboration Agreement between Protagonist Therapeutics, Inc. and Janssen Biotech, Inc.
License Agreements
Protagonist Therapeutics, Inc
Biotechnology
2019
Protagonist Therapeutics Inc. Employment Offer Letter to Donald Kalkofen for Chief Financial Officer Position
Employment Agreements
Protagonist Therapeutics, Inc
Biotechnology
2019
Separation Agreement between Protagonist Therapeutics, Inc. and Richard S. Shames, M.D. dated May 7, 2019
Separation Agreements
Protagonist Therapeutics, Inc
Biotechnology
CA
2019
First Amendment to Lease Agreement between BMR-Pacific Research Center LP and Protagonist Therapeutics, Inc.
Lease Agreements
Protagonist Therapeutics, Inc
Biotechnology
2019
Employee Severance Agreement between Protagonist Therapeutics, Inc. and Suneel Gupta, Ph.D.
Severance Agreements
Protagonist Therapeutics, Inc
Biotechnology
CA
2019
Protagonist Therapeutics, Inc. Warrant to Purchase Common Stock Agreement
Warrant Agreements
Protagonist Therapeutics, Inc
Biotechnology
NY
2018
Protagonist Therapeutics and Stockholders Section 3(a)(9) Exchange Agreement (December 2018)
Exchange Agreements
Protagonist Therapeutics, Inc
Biotechnology
2018
Protagonist Therapeutics Inc. Part-Time Chief Development Officer Employment Agreement with Samuel Saks (May 21, 2018)
Employment Agreements
Protagonist Therapeutics, Inc
Biotechnology
2018
Class A Common Stock Purchase Warrant Agreement between Protagonist Therapeutics, Inc. and Holder
Warrant Agreements
Protagonist Therapeutics, Inc
Biotechnology
2018
Class B Common Stock Purchase Warrant Agreement between Protagonist Therapeutics, Inc. and Holder
Warrant Agreements
Protagonist Therapeutics, Inc
Biotechnology
2018
Protagonist Therapeutics, Inc. Registration Rights Agreement with Purchasers (August 2018)
Registration Rights Agreements
Protagonist Therapeutics, Inc
Biotechnology
DE
2018
Underwriting Agreement between Protagonist Therapeutics, Inc. and Underwriters (Leerink Partners LLC, Barclays Capital Inc.) for 3,530,000 Shares of Common Stock
Underwriting Agreements
Protagonist Therapeutics, Inc
Biotechnology
DE
2017
License and Collaboration Agreement between Janssen Biotech, Inc. and Protagonist Therapeutics, Inc.
License Agreements
Protagonist Therapeutics, Inc
Biotechnology
NY
2017
Lease Agreement between BMR-Pacific Research Center LP and Protagonist Therapeutics, Inc. dated March 6, 2017
Lease Agreements
Protagonist Therapeutics, Inc
Biotechnology
CA
2017
Fourth Amendment to Lease Agreement between Berrueta Family L.P. and Protagonist Therapeutics, Inc.
Lease Agreements
Protagonist Therapeutics, Inc
Biotechnology
2016
Research Collaboration and License Agreement between Zealand Pharma A/S and Protagonist Entities (2012)
License Agreements
Protagonist Therapeutics, Inc
Biotechnology
NY
2016
Contract Extension to Research Collaboration and License Agreement between Zealand Pharma A/S and Protagonist Entities
Collaboration Agreements
Protagonist Therapeutics, Inc
Biotechnology
2016
Agreement on Addition of Additional Collaboration Program to Research Collaboration and License Agreement between Zealand Pharma A/S and Protagonist Therapeutics
Collaboration Agreements
Protagonist Therapeutics, Inc
Biotechnology
2016
Modification and Assumption of Collaboration Program Agreement between Protagonist Therapeutics Inc. and Zealand Pharma A/S
Modification Agreements
Protagonist Therapeutics, Inc
Biotechnology
2016
Patent Assignment Agreement between Zealand Pharma A/S and Protagonist Therapeutics, Inc.
Assignment Agreements
Protagonist Therapeutics, Inc
Biotechnology
NY
2016
Abandonment Agreement between Zealand Pharma A/S and Protagonist Therapeutics, Inc. and Protagonist Pty. Ltd.
Termination Agreements
Protagonist Therapeutics, Inc
Biotechnology
2016
Underwriting Agreement between Protagonist Therapeutics, Inc. and Underwriters (Leerink Partners LLC, Barclays Capital Inc.)
Underwriting Agreements
Protagonist Therapeutics, Inc
Biotechnology
DE
2016
Common Stock Certificate of Protagonist Therapeutics, Inc.
Stock Agreements
Protagonist Therapeutics, Inc
Biotechnology
2016
Protagonist Therapeutics, Inc. Third Amended and Restated Investor Rights Agreement (July 31, 2016)
Investor Rights Agreements
Protagonist Therapeutics, Inc
Biotechnology
DE
2016
Protagonist Therapeutics, Inc. 2016 Equity Incentive Plan
Equity Distribution Agreements
Protagonist Therapeutics, Inc
Biotechnology
DE
2016
Protagonist Therapeutics, Inc. 2016 Employee Stock Purchase Plan
Stock Agreements
Protagonist Therapeutics, Inc
Biotechnology
2016
Indemnity Agreement between Protagonist Therapeutics, Inc. and Indemnitee (2016)
Indemnification Agreements
Protagonist Therapeutics, Inc
Biotechnology
DE
2016
Employee Severance Agreement between Protagonist Therapeutics, Inc. and Dinesh V. Patel, Ph.D.
Severance Agreements
Protagonist Therapeutics, Inc
Biotechnology
CA
2016
Employee Severance Agreement between Protagonist Therapeutics, Inc. and David Y. Liu, Ph.D.
Severance Agreements
Protagonist Therapeutics, Inc
Biotechnology
CA
2016
Employee Severance Agreement between Protagonist Therapeutics, Inc. and William Hodder
Severance Agreements
Protagonist Therapeutics, Inc
Biotechnology
CA
2016
Employee Severance Agreement between Protagonist Therapeutics, Inc. and Thomas P. O’Neil
Severance Agreements
Protagonist Therapeutics, Inc
Biotechnology
CA
2016
Employee Severance Agreement between Protagonist Therapeutics, Inc. and Richard S. Shames, M.D.
Severance Agreements
Protagonist Therapeutics, Inc
Biotechnology
CA
2016
Second Amended and Restated Investor Rights Agreement between Protagonist Therapeutics, Inc. and Preferred Stockholders (July 10, 2015)
Investor Rights Agreements
Protagonist Therapeutics, Inc
Biotechnology
DE
2016
Protagonist Therapeutics, Inc. 2007 Stock Option and Incentive Plan (As Amended and Restated)
Stock Agreements
Protagonist Therapeutics, Inc
Biotechnology
DE
2016
Lease Agreement between Berrueta Family Partnership and Protagonist Therapeutics, Inc. for 521 Cottonwood Drive, Milpitas, CA
Lease Agreements
Protagonist Therapeutics, Inc
Biotechnology
2016
First Amendment to Lease Agreement between Berrueta Family Partnership and Protagonist Therapeutics, Inc.
Lease Agreements
Protagonist Therapeutics, Inc
Biotechnology
2016
Second Amendment to Lease Agreement between Berrueta Family L.P. and Protagonist Therapeutics, Inc.
Lease Agreements
Protagonist Therapeutics, Inc
Biotechnology
2016
Third Amendment to Lease Agreement between Berrueta Family L.P. and Protagonist Therapeutics, Inc. (521 Cottonwood Dr., Milpitas, CA)
Lease Agreements
Protagonist Therapeutics, Inc
Biotechnology
2016
Research Collaboration and License Agreement between Zealand Pharma A/S and Protagonist Entities
License Agreements
Protagonist Therapeutics, Inc
Biotechnology
NY
2016
Contract Extension to Research Collaboration and License Agreement between Zealand Pharma A/S and Protagonist Entities
Collaboration Agreements
Protagonist Therapeutics, Inc
Biotechnology
2016
Agreement on Addition of Additional Collaboration Program to Research Collaboration and License Agreement between Zealand Pharma A/S and Protagonist Entities
Collaboration Agreements
Protagonist Therapeutics, Inc
Biotechnology
2016
Modification and Assumption of Collaboration Program Agreement between Protagonist Therapeutics Inc. and Zealand Pharma A/S
Modification Agreements
Protagonist Therapeutics, Inc
Biotechnology
2016
Patent Assignment Agreement between Zealand Pharma A/S and Protagonist Therapeutics, Inc.
Assignment Agreements
Protagonist Therapeutics, Inc
Biotechnology
NY
2016
Abandonment Agreement between Zealand Pharma A/S and Protagonist Therapeutics, Inc. and Protagonist Pty. Ltd.
Termination Agreements
Protagonist Therapeutics, Inc
Biotechnology
2016
Right of First Negotiation Agreement between Johnson & Johnson Development Corporation and Protagonist Therapeutics, Inc.
Investor Rights Agreements
Protagonist Therapeutics, Inc
Biotechnology
2016